Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • Hypoxia-inducible factors in disease pathophysiology and therapeutics (Oct 2020)
    • Latency in Infectious Disease (Jul 2020)
    • Immunotherapy in Hematological Cancers (Apr 2020)
    • Big Data's Future in Medicine (Feb 2020)
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • View all review series ...
  • Viewpoint
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
The Staphylococcus aureus Map protein is an immunomodulator that interferes with T cell–mediated responses
Lawrence Y. Lee, … , Damien McDevitt, Eric L. Brown
Lawrence Y. Lee, … , Damien McDevitt, Eric L. Brown
Published November 15, 2002
Citation Information: J Clin Invest. 2002;110(10):1461-1471. https://doi.org/10.1172/JCI16318.
View: Text | PDF
Article Infectious disease

The Staphylococcus aureus Map protein is an immunomodulator that interferes with T cell–mediated responses

  • Text
  • PDF
Abstract

Research Article

Authors

Lawrence Y. Lee, Yuko J. Miyamoto, Bradley W. McIntyre, Magnus Höök, Kirk W. McCrea, Damien McDevitt, Eric L. Brown

×

Figure 2

Options: View larger image (or click on image) Download as PowerPoint
The number of bacteria isolated from various tissues. CFUs from blood, h...
The number of bacteria isolated from various tissues. CFUs from blood, heart, kidneys, and joints were determined from mice infected with either Map–SA (open squares) or Map+SA (filled squares) at various times after infection. Data are expressed as the mean CFU ± SE of the mean of 4 mice/group at each time point. There was no statistical differences between infection groups at any of the time points examined (Student t test). *The bacterial density in the joints harvested from Map–SA–infected mice 4 days after infection was 5,750 ± 2,453.
Follow JCI:
Copyright © 2021 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts